Views & Analysis Making it as an oncology biotech in the UK We speak to R&D experts to find out how oncology biotechs can get the support they need to be successful in the competitive UK ecosystem
News Disc maps out US filing for porphyria drug bitopertin Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.